MARATTO

article · Benha Journal of Applied Sciences

Acne Vulgaris: Pathogenesis, Clinical Manifestations and Therapeutic Lines

2025Open accessAlexandria University

Abstract

One example of a chronic inflammatory condition is acne vulgaris. Causes of chronic acne include overproduction of sebum, abnormal follicular infundibulum keratinisation, the spread of bacteria, and subsequent inflammation, as well as endocrinological variables like androgens. The pathophysiology of this condition usually starts in the early teen years but may continue far into adulthood. The most common areas to find lesions are on the chest, upper back, neck, and face. Among the many types of acne, you may find those specific to certain situations or occupations, such as neonatal or infantile acne, acne conglobata, acne fulminans, acne mechanica, excoriated acne, chloracne, or acne produced by certain medications, such as anabolic steroids, corticosteroids, lithium, or phenytoin. To lessen the emotional and social toll of the condition, there are a number of helpful medication options, both topically and systemically applied. Oral medications (such as tetracyclines, macrolides, and isotretinoin) and hormonal treatments (such as oral contraceptives and systemic glucocorticoids or GnRH agonists) are the most common methods of treating acne vulgaris, although topical medications (like benzoyl peroxide (BP), topical antibiotics, retinoids, azelaic acid, dapsone, etc.) and oral medications in general are also used frequently.

Research topics

  • Acne and Rosacea Treatments and Effects
  • Oral Health Pathology and Treatment
  • Plant-based Medicinal Research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bjas.2025.357410.1580

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.